CORE LABORATORIES N.V. Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)

CORE LABORATORIES N.V. reported Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) of -$3.89 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-10.

Discontinued › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards

us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation · last filed 2023-02-10

CORE LABORATORIES N.V. defined benefit plan, benefit obligation, foreign currency translation gain (loss) for fiscal 2022 was -$3.89M.
CORE LABORATORIES N.V. defined benefit plan, benefit obligation, foreign currency translation gain (loss) for fiscal 2021 was -$5.17M, a 185.03% decline from fiscal 2020.
CORE LABORATORIES N.V. defined benefit plan, benefit obligation, foreign currency translation gain (loss) for fiscal 2020 was $6.08M.
CORE LABORATORIES N.V. defined benefit plan, benefit obligation, foreign currency translation gain (loss) for fiscal 2019 was -$1.34M.

Period end	Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) 12 month	Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) 12 month as first filed
2022-12-31	-$3.89M 10-K · filed 2023-02-10
2021-12-31	-$5.17M 10-K · filed 2023-02-10
2020-12-31	$6.08M 10-K · filed 2022-02-10
2019-12-31	-$1.34M 10-K · filed 2021-02-08
2018-12-31	-$2.32M 10-K · filed 2020-02-10	$2.32M 10-K · filed 2019-02-11
2017-12-31	-$6.95M 10-K · filed 2019-02-11	$6.95M 10-K · filed 2018-02-12
2016-12-31	-$1.52M 10-K · filed 2018-02-12
2015-12-31	-$5.99M 10-K · filed 2017-02-10
2014-12-31	-$7.61M 10-K · filed 2016-02-12
2013-12-31	$2.02M 10-K · filed 2015-02-17
2012-12-31	$843.00K 10-K · filed 2014-02-13
2011-12-31	-$839.00K 10-K · filed 2013-02-19
2010-12-31	-$2.25M 10-K · filed 2012-02-15